Featured Research

from universities, journals, and other organizations

Newborns exposed to methamphetamine before birth are hard to arouse, hard to calm down, study suggests

Date:
May 2, 2011
Source:
American Academy of Pediatrics
Summary:
A scale used to assess the behavior of newborns exposed to methamphetamine before birth might be able to identify those children who will develop problems later on.

A scale used to assess the behavior of newborns exposed to methamphetamine before birth might be able to identify those children who will develop problems later on, according to a study presented on May 1, at the Pediatric Academic Societies (PAS) annual meeting in Denver.

A large body of research shows that prenatal exposure to cocaine can lead to cognitive and behavioral problems in children. Recently, methamphetamine has become the drug of choice for many pregnant drug users, according to study co-author Barry M. Lester, PhD. Despite its widespread use, little is known about the potential consequences of prenatal meth exposure on the development of children.

Dr. Lester and his colleagues undertook the Infant Development, Environment, and Lifestyle (IDEAL) Study to look at the neurobehavioral effects of prenatal meth exposure in 185 newborns at four clinical centers. A comparison group included 195 newborns who were not exposed to methamphetamine but were exposed prenatally to alcohol, tobacco or marijuana. This allowed researchers to tease out any effects due to methamphetamine exposure rather than effects that may have been due to other substances commonly used in conjunction with meth.

Researchers used the NICU Network Neurobehavioral Scale (NNNS) to evaluate the newborns during the first four days of life and again at 1 month of age. The NNNS assesses muscle tone, reflexes, behavioral state, motor development and stress.

"There are certain characteristics that are real clues to whether or not the baby does well later on. Stress is one of them, arousal is another," said Dr. Lester, who has studied babies exposed to cocaine in utero.

Results showed that newborns whose mothers used methamphetamine while pregnant were hard to arouse, but once awakened, they could not be calmed easily, said Dr. Lester, professor of psychiatry and pediatrics and director of the Center for the Study of Children at Risk at the Warren Alpert Medical School of Brown University and Women & Infants Hospital.

At 1 month, improvements were seen in arousal and total stress among the methamphetamine-exposed group. In addition, both groups showed higher quality of movement, less lethargy and fewer asymmetric reflexes.

"The beauty of these data is showing that we can identify the kids who are doing well, those that improved," Dr. Lester said. "We can also pull out the ones who are not doing as well and arrange intervention and prevention services for them before some abnormality shows itself."

Dr. Lester noted that many babies are labeled "high-risk," but there aren't enough resources to provide treatment services to all of them. If those likely to develop problems later on can be identified based on neurobehavior shortly after birth, then intervention services can be targeted to that group.

Dr. Lester acknowledged that prevention is hard to sell, especially in today's economy. However, he said, "The amount of money it takes to do the intervention compared to the amount of money spent later on for these kids for special education is pocket change."


Story Source:

The above story is based on materials provided by American Academy of Pediatrics. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Pediatrics. "Newborns exposed to methamphetamine before birth are hard to arouse, hard to calm down, study suggests." ScienceDaily. ScienceDaily, 2 May 2011. <www.sciencedaily.com/releases/2011/05/110501183651.htm>.
American Academy of Pediatrics. (2011, May 2). Newborns exposed to methamphetamine before birth are hard to arouse, hard to calm down, study suggests. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/05/110501183651.htm
American Academy of Pediatrics. "Newborns exposed to methamphetamine before birth are hard to arouse, hard to calm down, study suggests." ScienceDaily. www.sciencedaily.com/releases/2011/05/110501183651.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins